MRP3: a molecular target for human glioblastoma multiforme immunotherapy.

BACKGROUND: Glioblastoma multiforme (GBM) is refractory to conventional therapies. To overcome the problem of heterogeneity, more brain tumor markers are required for prognosis and targeted therapy. We have identified and validated a promising molecular therapeutic target that is expressed by GBM: h...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuan, Chien-Tsun, Wakiya, Kenji, Herndon, James E, Lipp, Eric S, Pegram, Charles N, Riggins, Gregory J, Rasheed, Ahmed, Szafranski, Scott E, McLendon, Roger E, Wikstrand, Carol J, Bigner, Darell D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940806/
https://www.ncbi.nlm.nih.gov/pubmed/20809959
http://dx.doi.org/10.1186/1471-2407-10-468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940806/
https://www.ncbi.nlm.nih.gov/pubmed/20809959
http://dx.doi.org/10.1186/1471-2407-10-468

Ejemplares similares